FDA Clearance Tracker · K200839
APAS Independence with IC Chromogenic MRSA BD Analysis Module; APAS Independence with IC Chromogenic MRSA TFS/S Analysis Module
Last checked: Nov 20, 2026Latest source record: Oct 28, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Oct 28, 2021
Substantially Equivalent
Time to decision
576 days
Received Mar 31, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K200839
- Device name
- APAS Independence with IC Chromogenic MRSA BD Analysis Module; APAS Independence with IC Chromogenic MRSA TFS/S Analysis Module
- Applicant
- Clever Culture Systems
- Applicant location
- Bach, CH
- Received
- Mar 31, 2020
- Decided
- Oct 28, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.2190
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QQY (Culture Plate Imaging System For Qualitative Assessment Of Resistant Organisms).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K200839
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Clever Culture Systems
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K183648 · Decided May 15, 2019 · 140 days after receipt
Device type: Microbial Colony Image Assessment System (PPU) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.